This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Duke University. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations in Cancer Treatment by Steven Patierno
Introduction
Steven Patierno is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of splice-switching oligonucleotides. His work aims to provide new methods for combating cancer by targeting specific gene expressions.
Latest Patents
Patierno holds a patent for "Splice-switching oligonucleotides and methods of use." This patent outlines methods and compositions designed for the treatment of cancer. The disclosure provides splice-switching oligonucleotides that downregulate the expression of AR or EGFR, offering potential new avenues for cancer therapy.
Career Highlights
Steven Patierno is affiliated with Duke University, where he continues to advance his research in cancer treatment. His work has garnered attention for its innovative approach to utilizing splice-switching oligonucleotides in therapeutic applications.
Collaborations
Patierno collaborates with notable colleagues, including Jennifer Freedman and Brendon Patierno. Their combined expertise contributes to the ongoing research and development of effective cancer treatments.
Conclusion
Steven Patierno's contributions to cancer treatment through his patented innovations highlight the importance of research in developing new therapeutic methods. His work at Duke University and collaborations with fellow researchers continue to pave the way for advancements in oncology.